- Home
- RMBS vs KZR Comparison
RMBS vs KZR Comparison
Compare RMBS & KZR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RMBS | KZR |
|---|---|---|
| Founded | 1990 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.2B | 45.8M |
| IPO Year | 1997 | 2018 |
Fundamental Metrics
Financial Performance| Metric | RMBS | KZR |
|---|---|---|
| Price | $104.83 | $6.17 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 7 | 4 |
| Target Price | ★ $102.00 | $6.00 |
| AVG Volume (30 Days) | ★ 1.4M | 34.0K |
| Earning Date | 02-02-2026 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 30.64 | N/A |
| EPS | ★ 2.10 | N/A |
| Revenue | ★ $678,488,000.00 | N/A |
| Revenue This Year | $29.01 | N/A |
| Revenue Next Year | $16.23 | N/A |
| P/E Ratio | $47.88 | ★ N/A |
| Revenue Growth | ★ 31.05 | N/A |
| 52 Week Low | $40.12 | $3.53 |
| 52 Week High | $114.55 | $6.65 |
Technical Indicators
Market Signals| Indicator | RMBS | KZR |
|---|---|---|
| Relative Strength Index (RSI) | 61.07 | 47.69 |
| Support Level | $88.50 | $6.04 |
| Resistance Level | $95.35 | $6.27 |
| Average True Range (ATR) | 4.11 | 0.10 |
| MACD | 0.90 | -0.03 |
| Stochastic Oscillator | 76.83 | 33.33 |
Price Performance
Historical ComparisonAbout RMBS Rambus Inc.
Rambus Inc is a semiconductor solutions provider offering high-speed, high-security computer chips and Silicon intellectual property. The company's key products include memory interface chips, built for high speed and efficiency; silicon IP, providing high-speed memory and chip-to-chip connection technology; and architecture licenses, which allow customers to use portions of Rambus' patented inventions for their own digital electronics. The firm receives the majority of its revenue from the United States, Taiwan, Asia, Japan, and Singapore.
About KZR Kezar Life Sciences Inc.
Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetomipzomib (KZR-616), and KZR-261.